Contribute Try STAT+ Today

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a cool breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation. Our choice today is maple bourbon. Yum. Meanwhile, here are a few items of interest. Have a grand day, and drop us a line if you hear something saucy. …

Internal documents cited during opening remarks of a landmark opioid trial in Cleveland suggest the nation’s biggest pharmacy chains were warned by employees about dispensing the addictive painkillers, NPR says. Mark Lanier, an attorney for two Ohio counties suing CVS Health (CVS), Giant Eagle, Walgreens (WBA), and Walmart (WMT), read the documents in his opening statement. “Walgreens is not verifying the legitimacy of suspicious orders, which could lead to the fulfilment of an illicit order,” said one Walgreens memo cited by Lanier. A separate communication from a CVS employee warned that company safeguards, designed to reduce prescription opioid abuse, might be inadequate.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment